Other languages Sandu Pharmaceuticals Limited

Equities

SANDUPHQ6

INE751D01014

Market Closed - Bombay S.E. Other stock markets 03:56:30 31/05/2024 pm IST			5-day change	1st Jan Change
59.5 ^INR	-0.28%		-0.77%	-12.63%

30/03	Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer	CI
30/03	Sandu Pharmaceuticals Limited Announces Executive Changes	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sandu Pharmaceuticals Limited Appoints Shri Vijay Kajrekar as Chief Financial Officer	30/03
Sandu Pharmaceuticals Limited Announces Executive Changes	30/03
Sandu Pharmaceuticals Board Mulls CFO Appointment	20/03
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Sandu Pharmaceuticals CFO to Step Down in December	22/11
Sandu Pharmaceuticals Limited Announces CFO Changes	22/11
Sandu Pharmaceuticals' Consolidated Net Profit Slips in Fiscal Q2	14/11
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	13/11
Sandu Pharmaceuticals Limited Approves Change in Directorate	30/23/30
Sandu Pharmaceuticals Shuts Goa, India Plant for Renovation	18/23/18
Sandu Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023	06/23/06
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31St March 2023	14/23/14
Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/23/14
Sandu Pharmaceuticals Expands Partnership with Vietnam's Bach Ma Van Xuan; Shares Jump 3%	12/22/12
Sandu Pharmaceuticals Limited Enters into Memorandum of Understanding with Bach Ma Van Xuan Pharmaceuticals	10/22/10
Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/22/14
Sandu Pharmaceuticals Limited Approves Dividend for the Financial Year Ended March 31, 2022	01/22/01
Sandu Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended 31 March 2022	12/22/12
Sandu Pharmaceuticals Forms New Subsidiary for Phytoceuticals Products	28/22/28
Sandu Pharmaceuticals Limited Incorporates Subsidiary	27/22/27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sandu Pharmaceuticals Limited

Equities

SANDUPHQ6

INE751D01014

Other languages

Filters